UQ and Vaxxas Win Global Prize to Revolutionize mRNA Vaccine Delivery with Painless Patch
14 Jan 2025
In an exciting breakthrough for global healthcare, the University of Queensland (UQ) and biotechnology company Vaxxas have won a prestigious global prize to accelerate the development of a patch-based mRNA vaccine for COVID-19. This achievement is part of their collaboration on advancing Vaxxas' high-density microarray patch (HD-MAP) technology. The partnership...
Read More